JAMES BANIGAN and RICHARD TEMPLIN, et al. v. ORGANON USA INC., et al. ORDER. August 23, 2016. ZOBEL, J. Before the court are two motions for ...
“Off–Label Marketing Claims Against Organon To state a claim under FCA ... Harvey Kurzweil, Suzanne Jaffe Bloom, New York, NY, for Organon USA Inc., et al.
Owens-Illinois, Inc., 191 Cal. App. 3d 1341 .... Organon USA Inc. and Akzo .... 33.33%. Blake v. Abbott. Laboratories, et al., No. L-. 8950 (Cir. Ct. Blount. County ...
Feb 25, 2014 ... ... does not appear to affect rScO2 as determined by NIRS (Nissen et al., 2009). ... Somanetics, Troy, MI, USA) was used to detect rScO2 and SmO2. ... Neuromuscular blockade was evaluated with “train of four” (Organon Dublin, Ireland). ..... W. A., Roy S., Kuppusamy P., Bergdall V., Gordillo G. M., et al.
Aug 15, 2016 ... acetylcholine receptor a subunit based on Criado et al. (1985). NWK ' ... kit from U . S. Biochemical Corp. ... the construct PBal (Blount and Merlie, 1988) by oligonucleotide- ... Organon Teknika (West Chester, PA). ..... V. R. Lingappa and the members of his laboratory, for their advice ... U. S. A. 82, 2004-2008.
Jun 13, 2008 ... ... kindly provided by A. Grootenhuis and J. Verhagen of (N.V. Organon). ..... The American Society for Biochemistry and Molecular Biology, Inc. ... Lewis, K. A., Gray, P. C., Blount, A. L., MacConell, L. A., Wiater, E., Bilezikjian, L. M. ... U. S. A. 83, 5849-5853 .... Susan Maynard et al., Clinical Pain Advisor, 2016.
May 1, 2014 ... Director, Blount Medicine Attending Service ..... Organon USA .... et al. A randomized comparison of deferasirox versus deferoxamine for .... ley & Balfers, Inc., Philadelphia, PA, March, Second Edition 1992 and Third Edition,.
Feb 1, 2007 ... 0.15 vs. 0.24. 0.05; P < 0.001, respectively). The 31-kDa inhibin B was ... Printed in U.S.A. ... The method of Scott et al. (21) was employed, except FSH release ... provided by A. Grootenhuis and J. Verhagen of N.V. Organon (The ... preparation (R&D Systems Inc., Minneapolis, MN) was used as reference.
Printed in U.S.A.. Copyright © 2002 by The ... F12 containing 2% Ultroser (Life Technologies, Inc., Paisley, Scotland),. ITS1 liquid media ... Organon, Oss, Holland), 8-bromoadenosine cAMP (8-BrcAMP) (Sigma), ..... 0.05 comparing control vs. treatment. FIG. 1. ... secretion, in line with the studies of Spencer et al. ( 5, 17, 18),.